Abiopharma

Edgewise Therapeutics - Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026

U.S. Bank Wealth Management Names Chris Peary Chief Private Banking Officer

PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile

flyExclusive Appoints Brian P. Reid as Chief Commercial Officer

Farmers & Merchants Bank of Long Beach Declares Third-Quarter Cash Dividend Payment of $28 Per Share

Kimbell Royalty Partners Boosts 2026 Production Guidance

Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan

Evolution Metals & Technologies Corp. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes

ASML reports transactions under its current share buyback program

Kentucky PSC Approves 482 MW Power Agreement for TeraWulf’s Justified Data Campus

McGraw Hill, Inc. to Participate in Investor Events

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards

The9 Reports US$32 Million Net Income for Second Quarter of 2026, Up Over 39% Sequentially